Oncopeptides strives to ensure that analysts, investors, shareholders and financial media are provided with correct information to enhance understanding of our operations.
Oncopeptides strives to ensure that analysts, investors, shareholders and financial media are provided with correct information to enhance understanding of our operations.
Nasdaq Stockholm
Price
Change
WEBCAST
Oncopeptides AB published the report for the third quarter 2026, at 08:00 CET November 5, 2026. Investors, financial analysts, and media were invited to participate in a webcast and a subsequent Q&A session on November 5 at 09:00 CET.
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care